Novastan argatroban: Began Phase II/III trial of safety and efficacy; results should be available by late 1996

Texas Biotechnology Corp. (TXB), Houston Product: Novastan argatroban, small molecule thrombin inhibitor Indication: Heparin-induced thrombocytopenia thrombosis syndrome, a complication of heart su...